Annual EBIT
-$75.25 M
+$3.13 M+3.99%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual earnings before interest & taxes is -$75.25 million, with the most recent change of +$3.13 million (+3.99%) on December 31, 2023.
- During the last 3 years, ACHL annual EBIT has fallen by -$41.53 million (-123.13%).
- ACHL annual EBIT is now -446.32% below its all-time high of -$13.78 million, reached on December 31, 2019.
Performance
ACHL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.42 M
-$2.62 M-14.71%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly earnings before interest & taxes is -$20.42 million, with the most recent change of -$2.62 million (-14.71%) on September 1, 2024.
- Over the past year, ACHL quarterly EBIT has dropped by -$903.00 thousand (-4.63%).
- ACHL quarterly EBIT is now -266.82% below its all-time high of -$5.57 million, reached on March 31, 2020.
Performance
ACHL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$72.03 M
-$1.32 M-1.87%
September 1, 2024
Summary
- As of February 7, 2025, ACHL TTM earnings before interest & taxes is -$72.03 million, with the most recent change of -$1.32 million (-1.87%) on September 1, 2024.
- Over the past year, ACHL TTM EBIT has increased by +$3.23 million (+4.29%).
- ACHL TTM EBIT is now -1194.09% below its all-time high of -$5.57 million, reached on March 31, 2020.
Performance
ACHL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ACHL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.0% | -4.6% | +4.3% |
| 3 y3 years | -123.1% | -27.3% | +2.7% |
| 5 y5 years | -446.3% | -27.3% | +2.7% |
ACHL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | +4.0% | -42.8% | +10.6% | -12.2% | +8.3% |
| 5 y | 5-year | -446.3% | +4.0% | -266.8% | +10.6% | -1194.1% | +8.3% |
| alltime | all time | -446.3% | +4.0% | -266.8% | +10.6% | -1194.1% | +8.3% |
Achilles Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.42 M(+14.7%) | -$72.03 M(+1.9%) |
| Jun 2024 | - | -$17.80 M(+24.5%) | -$70.71 M(-0.4%) |
| Mar 2024 | - | -$14.30 M(-26.7%) | -$71.00 M(-5.7%) |
| Dec 2023 | -$75.25 M(-4.0%) | -$19.51 M(+2.2%) | -$75.25 M(-4.2%) |
| Sep 2023 | - | -$19.10 M(+5.5%) | -$78.58 M(+4.1%) |
| Jun 2023 | - | -$18.09 M(-2.5%) | -$75.51 M(-3.1%) |
| Mar 2023 | - | -$18.55 M(-18.7%) | -$77.97 M(-0.5%) |
| Dec 2022 | -$78.38 M | -$22.83 M(+42.4%) | -$78.38 M(+5.9%) |
| Sep 2022 | - | -$16.03 M(-22.0%) | -$74.01 M(+0.4%) |
| Jun 2022 | - | -$20.55 M(+8.3%) | -$73.71 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$18.97 M(+2.8%) | -$69.46 M(+8.2%) |
| Dec 2021 | -$64.19 M(+90.3%) | -$18.46 M(+17.3%) | -$64.19 M(+9.4%) |
| Sep 2021 | - | -$15.74 M(-3.4%) | -$58.65 M(+14.5%) |
| Jun 2021 | - | -$16.29 M(+18.8%) | -$51.22 M(+22.3%) |
| Mar 2021 | - | -$13.71 M(+6.1%) | -$41.87 M(+24.1%) |
| Dec 2020 | -$33.73 M(+144.8%) | -$12.92 M(+55.7%) | -$33.73 M(+62.1%) |
| Sep 2020 | - | -$8.30 M(+19.6%) | -$20.81 M(+66.4%) |
| Jun 2020 | - | -$6.94 M(+24.7%) | -$12.51 M(+124.7%) |
| Mar 2020 | - | -$5.57 M | -$5.57 M |
| Dec 2019 | -$13.78 M | - | - |
FAQ
- What is Achilles Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Achilles Therapeutics?
- What is Achilles Therapeutics annual EBIT year-on-year change?
- What is Achilles Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly EBIT year-on-year change?
- What is Achilles Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Achilles Therapeutics?
- What is Achilles Therapeutics TTM EBIT year-on-year change?
What is Achilles Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ACHL is -$75.25 M
What is the all time high annual EBIT for Achilles Therapeutics?
Achilles Therapeutics all-time high annual earnings before interest & taxes is -$13.78 M
What is Achilles Therapeutics annual EBIT year-on-year change?
Over the past year, ACHL annual earnings before interest & taxes has changed by +$3.13 M (+3.99%)
What is Achilles Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ACHL is -$20.42 M
What is the all time high quarterly EBIT for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly earnings before interest & taxes is -$5.57 M
What is Achilles Therapeutics quarterly EBIT year-on-year change?
Over the past year, ACHL quarterly earnings before interest & taxes has changed by -$903.00 K (-4.63%)
What is Achilles Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ACHL is -$72.03 M
What is the all time high TTM EBIT for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM earnings before interest & taxes is -$5.57 M
What is Achilles Therapeutics TTM EBIT year-on-year change?
Over the past year, ACHL TTM earnings before interest & taxes has changed by +$3.23 M (+4.29%)